These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 2811008)
21. Nontuberculous mycobacterial infection of the lung in a chest hospital in Thailand. Wongwatana S; Sriyabhaya N J Med Assoc Thai; 1992 Jan; 75(1):1-10. PubMed ID: 1602257 [TBL] [Abstract][Full Text] [Related]
22. [A supplement study on the in vitro activity of sulfadimethoxine on Mycobacterium avium complex--combined effect with other antituberculosis drugs]. Tsukamura M Kekkaku; 1989 Jun; 64(6):379-86. PubMed ID: 2507819 [TBL] [Abstract][Full Text] [Related]
23. [Pulmonary infection caused by Mycobacterium szulgai: a case report]. Ikeue T; Watanabe S; Sugita T; Horikawa S; Suzuki Y; Nishiyama H; Maekawa N Kekkaku; 2002 May; 77(5):427-31. PubMed ID: 12073621 [TBL] [Abstract][Full Text] [Related]
24. [Clinical analysis of 41 cases of pulmonary atypical mycobacteriosis]. Xia XX Zhonghua Jie He He Hu Xi Za Zhi; 1992 Aug; 15(4):200-1, 253. PubMed ID: 1307510 [TBL] [Abstract][Full Text] [Related]
25. Frequency of embB codon 306 mutations in ethambutol-susceptible and -resistant clinical Mycobacterium tuberculosis isolates in Kuwait. Ahmad S; Jaber AA; Mokaddas E Tuberculosis (Edinb); 2007 Mar; 87(2):123-9. PubMed ID: 17289435 [TBL] [Abstract][Full Text] [Related]
26. [Analysis on the current situation of Mycobacteria other than tuberculosis during 1994-2003 in the old city area of Guangzhou]. Liu ZH; Luo CM; Cai XS Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Jun; 26(6):424-7. PubMed ID: 16185454 [TBL] [Abstract][Full Text] [Related]
27. Mycobacterium szulgai in a patient with advanced acquired immunodeficiency syndrome: an unusual pathogen with unusual multidrug resistance. Kang-Birken SL; Prichard JG Pharmacotherapy; 2006 Nov; 26(11):1646-9. PubMed ID: 17064210 [TBL] [Abstract][Full Text] [Related]
28. Combined versus single antituberculosis drugs on the in vitro sensitivity patterns of non-tuberculous mycobacteria. Banks J; Jenkins PA Thorax; 1987 Nov; 42(11):838-42. PubMed ID: 3424264 [TBL] [Abstract][Full Text] [Related]
29. Combined vs. single-drug studies of susceptibilities of Mycobacterium kansasii to isoniazid, streptomycin, and ethambutol. Tsang AY; Bentz RR; Schork MA; Sodeman TM Am J Clin Pathol; 1978 Nov; 70(5):816-20. PubMed ID: 717288 [TBL] [Abstract][Full Text] [Related]
30. [A case report of pulmonary Mycobacterium kansasii infection found regular medical examination in our medical college of nursing]. Inatomi K Kekkaku; 2000 Nov; 75(11):661-4. PubMed ID: 11140089 [TBL] [Abstract][Full Text] [Related]
31. Photochromogenic and scotochromogenic mycobacteria: their clinical significance. Gimpl F Acta Microbiol Acad Sci Hung; 1979; 26(3):185-92. PubMed ID: 543456 [TBL] [Abstract][Full Text] [Related]
32. [A lupus-vulgaris like atypical mycobacteriosis caused by Mycobacterium xenopi (lupus xenopi)]. Kiehl P; Eicher U; Vakilzadeh F Hautarzt; 1992 Sep; 43(9):569-75. PubMed ID: 1399603 [TBL] [Abstract][Full Text] [Related]
33. [Identification of atypical mycobacteria isolated from clinical specimens by line probe assay (LIPA)]. Biçmen C; Coşkun M; Gündüz AT; Senol G; Cirak AK; Tibet G Mikrobiyol Bul; 2007 Oct; 41(4):503-10. PubMed ID: 18173068 [TBL] [Abstract][Full Text] [Related]
34. Evaluation of wild-type MIC distributions as a tool for determination of clinical breakpoints for Mycobacterium tuberculosis. Schön T; Juréen P; Giske CG; Chryssanthou E; Sturegård E; Werngren J; Kahlmeter G; Hoffner SE; Angeby KA J Antimicrob Chemother; 2009 Oct; 64(4):786-93. PubMed ID: 19633001 [TBL] [Abstract][Full Text] [Related]
35. Multifocal osteomyelitis due to Mycobacterium szulgai in a patient with chronic lymphocytic leukemia. Meyer JJ; Gelman SS J Infect; 2008 Feb; 56(2):151-4. PubMed ID: 18199481 [TBL] [Abstract][Full Text] [Related]
36. Synergistic activity of rifampicin and ethambutol against slow-growing nontuberculous mycobacteria is currently of questionable clinical significance. van Ingen J; Hoefsloot W; Mouton JW; Boeree MJ; van Soolingen D Int J Antimicrob Agents; 2013 Jul; 42(1):80-2. PubMed ID: 23664674 [TBL] [Abstract][Full Text] [Related]
37. [Multicenter evaluation of a newly developed microdilution test, brothMIC NTM to determine minimum inhibitory concentrations of antimicrobial agents for nontuberculous mycobacteria]. Yamane N; Onaga S; Saitoh H; Toyoshima S; Shimojima M; Kawahara S; Takashima T; Yamashita T Rinsho Byori; 2002 Apr; 50(4):381-91. PubMed ID: 12014018 [TBL] [Abstract][Full Text] [Related]
38. Spectrum of drugs against atypical mycobacteria: how valid is the current practice of drug susceptibility testing and the choice of drugs? Rastogi N; Goh KS; Guillou N; Labrousse V Zentralbl Bakteriol; 1992 Dec; 277(4):474-84. PubMed ID: 1303690 [TBL] [Abstract][Full Text] [Related]
39. [Distribution and drug resistance of nontuberculous Zhang J; Su JR; Ding BC; Liu JW; Yi JL; Yang XY; Wang NH; Wang SM Zhonghua Jie He He Hu Xi Za Zhi; 2017 Mar; 40(3):210-214. PubMed ID: 28297817 [No Abstract] [Full Text] [Related]